Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doesn't take a genius to point out the earth is flat either, but similarly I can see why some might believe it without any education.
So educate yourself.. go back and read many of the historical posts on this board, or do your own DD. Merle was cleared of those charges for one.
Yes... not a single CEO has ever bought shares as a method to signal company strength. And let's also ignore the millions of shares accumulated with relatively little price movement that has been building toward today (and isn't even close to done).
But you're right, nothing has changed with the fundamentals, and this stock should still be sitting at $5-$10 per share right now. Amazing buying level for those who have a very keen eye. I myself picked up some more to give to my kids down the road.
Almost beer time, TL.
If today wasn't clear in that regard, don't know what other signs people need.
Vrrrrrrrmmmmmmmmmmmmmmmm
We discussed Predictive Oncology a bit in the past, did not think there is any relation outside of name.. but interesting to see them there. May have to revisit.
OTC MM Speaks Out...
https://www.stockthoughts2.com/otc-market-maker-speaks-out/
Great read for those here, specifically the following paragraph given what we've seen lately in terms of accumulation by MM PAUL. Tides are going turn here quickly, and many are going to find themselves either out or trapped.
No question. Should not be under $10 currently IMO, but some of that is speculative on current dealings and includes potential in forecast.
Short-term who knows, but long-term it's a screaming buy. My neighbors have filed noise complaints twice already in that regard.
We only have data so far as of 11/15.
Aware, just have not seen that type of movement in my experience, and can not see the sentiment shared on other tickers from a quick search. Regardless, think we can agree that both trend dirty. Don't think it will matter though much longer.
That being said, nice to see our boy PAUL continually on the bid.
I wouldn't classify either as a major diluter, nor can I find that sentiment shared. Based off personal experience?
Market makers as seen on L2. Both are some of the most well known MMs for shorting.
Insider trading vs insider buying is not just limited to earnings filing dates. It's purely a function of having non-material and/or non-public information that would have significant influence on the security valuation.
Great post, but to clarify - 200 US doctors prescribing 35/mo would equate to revenue of $330M (assuming diagnostic sale at ~$3300 USD). The $150M is based upon 9 doctors/clinic across 12 clinics, representing 108 doctors.
That being said, there are 480+ fertility clinics in the US, and if all of which prescribed at that rate (with assumed avg. of 5 docs/clinic), we would be seeing the $3B.
Something I'm missing?
Yes. 12% for a cash/non-collateral loan (near 100% risk on the loaning party) of that size is fine. 12-15% is the standard, as normal corporate finance uses 15% cost of money in any NPV calculations.
Yes, very much depends on how large of a reduction we will see over the next few months... but agree that I confounded and over-generalized the two intents. You're right. Technically float reduction is almost just a shorting impact, but removing shares from the float also makes it clear to other investors how many shares are not expected to be trading and gives a matter of confidence IMO.
Smaller float means more price volatility. We have already seen a lot of accumulation and selling is starting to dry... when market buying steps in because selling slows, this thing could be poised to skyrocket - hence many of the large $ predictions (although not decoupled from potential news).
And what about tomorrow? Tomorrow is fake because it's not here yet. Or air, I cant see or hold it. Also fake.
Lol, time for me to take a break for the weekend. Enjoy yourselves.
If the lock-up/leak-out was in place, the compensated share amount may have been higher though. Tough to say given negotiations at the time, and risk I'm sure risk was evaluated but obviously we saw the worst case in the short-term.
I don't think we will see this again just given how companies tend to process/policy themselves out of past burns, but hard to gauge if it was a bad decision at the time or not and an oversight.
Very much this. Good post. Quality issues are a norm, outside of the companies control from a receipt standpoint (very good that they caught it ffom.many perspectives), and there is a normal process to resolve to get replacement stock or return of funds.
Only concern would be if this same issue comes up on future quarters again after resolved - showing poor supplier quality measures/engagement.
I agree, there are legitimate concerns in any company - even/especially this one. Based upon the overwhelming agenda and negativity by many posters and new accounts here over the past few months, I think many of the longs have taken to just pure positivity here to combat much of the BS and ignorance and other side. Doesn't mean that doesnt come with bs or ignorance of its own!
I'm more hoping for Nasdaq and price movement in the next few months just to get back to a seeming normalcy on this board if anything.
Yeah, I'm not discounting the possibility, although I'm not one to jump to conspiracy conclusions easily. Lol
Harder, yes... we all know that. Does not mean dead. Just means they are more willing, as expected, expected to dive more into the details and not just look at the surface level.
The surface level... not a clear picture and could be read in many ways (especially as seen here over the past few months). The detailed explanation is satisfactory, and not of concern, which is what matters for them.
QX does no where near as much vetting as the Nasdaq, or even CITIC/CLSA and other company investors/partners. This means two things:
1. It's much easier to get on, because they don't dive as much into the details.
2. It's much easier to get off, because they don't dive as much into the details.........
The CITIC/CLSA announcement, fact that Deloitte is still engaged, as well as no stated rejection by Nasdaq is evidence to whatever caused the delist to not being a concern. There are multiple legitimate reasons, as already posted by many, for why the company is not or can not go into details behind the delist.
Please do some more research into the Proalgazyne if you want to use the case to knock Brad or his character. Even a quick google search for would tell you that the product in question was not some snake oil equivalent. There are multiple current and previous scientific publications that highlight the benefits, as well as a completed clinical trial.
Lawsuits are very biased by nature by the plaintiffs - which was clearly the case here, and the end outcome was a settlement resolution that does not hold any fault or actual violations. In the end, I can find no legitimate fault by Brad here.. seems like normal dealings, and pissed off people trying to recoup money on a venture.
Hell, I've seen worse BS against me and my past teams for amounts in the tens to hundreds of millions.. and that's coming from parties that are still trying to grow their relationships for new business. lol
Lol, good point. China only has 4x the amount of births as the US on an annual basis. Clearly a dead market.
Welcome aboard.
Yep... and begin the getting caught up in stem cell revenue discussion all over again, lol. I for one am not nor have ever been an investor because of those products. They are a good interim source of cash and means to develop a sales/support team.
That said, there are always headwinds in industries - key for those that care will be to compare PREDs segment growth relative to competition.
Good luck with that.
Only issue right now is our own timeline. Pelco's posts have been spot on.
Picked some more up today at 0.99. Very happy.
The volume and movement has been nothing other than indicative of a large accumulation party. They are clearly holding the price level and once the selling dries then the price will start to be moved upward, which will also see very little resistance if done correctly. The steps will start off slow, but once they start rolling...
We've all seen the rumors here of a large buyback of the float. The past couple weeks of volume aligns perfectly (especially now that the market selling also appears to have dried).. I'm just hoping my additional funds clear tomorrow.
Great close today... very telling.
Buy when tensions are running on high... best corollary we have to low periods.
Regardless of how you wish to calculate, let's look at some other stocks to see how floats are structured... By yahoo.com (your equivalent) published value of float as a percentage of outstanding shares:
MSFT: 97.7%
AAPL: 92.7%
TSLA: 78.9%
NOW: 99.2%
GM: 87.4%
PFE: 99.99%
TMO: 99.8%
What's your point again?
Yep, you got it. We're all pumpers paid by Brad himself. Now that you've seen through our charade, might as well get a sizable short position!
Pretty clear.
Adding Monday... 0.15 seems to be a normal low-level, and this looks poised to go back to the 0.50 range in the next few months.
The 12/G-A you keep referencing is an amendment and represents a previous snapshot in time where those directors did not hold compensated shares. Read the latest 10-K, where the shares are adequately accounted for still.
Crazy that anyone believes the float is that large.
I miss the days when shorts had anything of substance to say. Now we're mostly dealing with things like "Brad uses the womenz bathroom!!1!".
If anything, these posts should be giving confidence in the company. That's really the best they can do? I can make up random facts all day too.
Speaking of which, I heard Bill Gates visited the PRED office this week. Melinda couldn't make it, but my source says she's going to be the company spokesperson.